Advertisement
UK markets close in 47 minutes
  • FTSE 100

    7,871.37
    -5.68 (-0.07%)
     
  • FTSE 250

    19,342.06
    -108.61 (-0.56%)
     
  • AIM

    744.04
    -1.25 (-0.17%)
     
  • GBP/EUR

    1.1659
    -0.0024 (-0.20%)
     
  • GBP/USD

    1.2444
    +0.0005 (+0.04%)
     
  • Bitcoin GBP

    51,694.90
    +486.21 (+0.95%)
     
  • CMC Crypto 200

    1,367.93
    +55.30 (+4.40%)
     
  • S&P 500

    4,999.45
    -11.67 (-0.23%)
     
  • DOW

    37,965.93
    +190.55 (+0.50%)
     
  • CRUDE OIL

    83.18
    +0.45 (+0.54%)
     
  • GOLD FUTURES

    2,402.40
    +4.40 (+0.18%)
     
  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     
  • HANG SENG

    16,224.14
    -161.73 (-0.99%)
     
  • DAX

    17,723.56
    -113.84 (-0.64%)
     
  • CAC 40

    8,024.28
    +1.02 (+0.01%)
     

Company News For Oct 2, 2017

Asbury Automotive (ABG) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
  • Shares of KB Homes KBH rallied 8.6% after reporting third quarter 2017 earnings of $0.51 per share, surpassing the Zacks Consensus Estimate of $0.47 a share

  • Tyson Foods, Inc.’s TSN shares surged 7.6% after the company raised its 2018 earnings outlook to $5.20 to $5.30 per share from $4.95 to $5.05 initially

  • Shares of Invesco Ltd. IVZ gained 2.2% after the company entered into an agreement to acquire Guggenheim's ETF business for about $1.2 billion in cash

  • Zogenix Inc.’s ZGNX shares rallied 172.2% after the company reported positive results from Phase 3 trial of the drug, ZX008 to cure epilepsy


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
KB Home (KBH) : Free Stock Analysis Report
 
Invesco PLC (IVZ) : Free Stock Analysis Report
 
Tyson Foods, Inc. (TSN) : Free Stock Analysis Report
 
Zogenix, Inc. (ZGNX) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research